aluates Reports

$ 0.0

Automative

Global Celiac Disease Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28G2866

Global Celiac Disease Market Insights and Forecast to 2028

BUY CHAPTERS

Global Celiac Disease Market Research Report 2025

Code: QYRE-Auto-28G2866

Report

September 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Merck

Johnson & Johnson

BioLineRx Ltd

Pfizer Inc

Innovate Biopharmaceuticals

ImmusanT

Novartis

Bristol–Myers Squibb

Immunomedics

Celiac Disease Market

The global market for Celiac Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Celiac Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Celiac Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Celiac Disease in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Celiac Disease include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis, Bristol-Myers Squibb, Immunomedics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Celiac Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Disease.

The Celiac Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celiac Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Celiac Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Celiac Disease Market Report

Report Metric	Details
Report Name	Celiac Disease Market
Segment by Type	Distension Diarrhea Anorexia Others
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis, Bristol-Myers Squibb, Immunomedics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Celiac Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Celiac Disease Market report?

Ans: The main players in the Celiac Disease Market are Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis, Bristol-Myers Squibb, Immunomedics

What are the Application segmentation covered in the Celiac Disease Market report?

Ans: The Applications covered in the Celiac Disease Market report are Hospital, Clinic

What are the Type segmentation covered in the Celiac Disease Market report?

Ans: The Types covered in the Celiac Disease Market report are Distension, Diarrhea, Anorexia, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Distension

1.2.3 Diarrhea

1.2.4 Anorexia

1.2.5 Others

1.3 Market by Application

1.3.1 Global Celiac Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Celiac Disease Market Perspective (2020-2031)

2.2 Global Celiac Disease Growth Trends by Region

2.2.1 Global Celiac Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Celiac Disease Historic Market Size by Region (2020-2025)

2.2.3 Celiac Disease Forecasted Market Size by Region (2026-2031)

2.3 Celiac Disease Market Dynamics

2.3.1 Celiac Disease Industry Trends

2.3.2 Celiac Disease Market Drivers

2.3.3 Celiac Disease Market Challenges

2.3.4 Celiac Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Celiac Disease Players by Revenue

3.1.1 Global Top Celiac Disease Players by Revenue (2020-2025)

3.1.2 Global Celiac Disease Revenue Market Share by Players (2020-2025)

3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Celiac Disease Revenue

3.4 Global Celiac Disease Market Concentration Ratio

3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2024

3.5 Global Key Players of Celiac Disease Head office and Area Served

3.6 Global Key Players of Celiac Disease, Product and Application

3.7 Global Key Players of Celiac Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Celiac Disease Breakdown Data by Type

4.1 Global Celiac Disease Historic Market Size by Type (2020-2025)

4.2 Global Celiac Disease Forecasted Market Size by Type (2026-2031)

5 Celiac Disease Breakdown Data by Application

5.1 Global Celiac Disease Historic Market Size by Application (2020-2025)

5.2 Global Celiac Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Celiac Disease Market Size (2020-2031)

6.2 North America Celiac Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Celiac Disease Market Size by Country (2020-2025)

6.4 North America Celiac Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Celiac Disease Market Size (2020-2031)

7.2 Europe Celiac Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Celiac Disease Market Size by Country (2020-2025)

7.4 Europe Celiac Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Celiac Disease Market Size (2020-2031)

8.2 Asia-Pacific Celiac Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Celiac Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Celiac Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Celiac Disease Market Size (2020-2031)

9.2 Latin America Celiac Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Celiac Disease Market Size by Country (2020-2025)

9.4 Latin America Celiac Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Celiac Disease Market Size (2020-2031)

10.2 Middle East & Africa Celiac Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Celiac Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Celiac Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Celiac Disease Introduction

11.1.4 Roche Revenue in Celiac Disease Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Celiac Disease Introduction

11.2.4 Merck Revenue in Celiac Disease Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Celiac Disease Introduction

11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 BiolineRx

11.4.1 BiolineRx Company Details

11.4.2 BiolineRx Business Overview

11.4.3 BiolineRx Celiac Disease Introduction

11.4.4 BiolineRx Revenue in Celiac Disease Business (2020-2025)

11.4.5 BiolineRx Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Celiac Disease Introduction

11.5.4 Pfizer Revenue in Celiac Disease Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Innovate Biopharmaceuticals

11.6.1 Innovate Biopharmaceuticals Company Details

11.6.2 Innovate Biopharmaceuticals Business Overview

11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction

11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2020-2025)

11.6.5 Innovate Biopharmaceuticals Recent Development

11.7 ImmusanT

11.7.1 ImmusanT Company Details

11.7.2 ImmusanT Business Overview

11.7.3 ImmusanT Celiac Disease Introduction

11.7.4 ImmusanT Revenue in Celiac Disease Business (2020-2025)

11.7.5 ImmusanT Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Celiac Disease Introduction

11.8.4 Novartis Revenue in Celiac Disease Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Celiac Disease Introduction

11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 Immunomedics

11.10.1 Immunomedics Company Details

11.10.2 Immunomedics Business Overview

11.10.3 Immunomedics Celiac Disease Introduction

11.10.4 Immunomedics Revenue in Celiac Disease Business (2020-2025)

11.10.5 Immunomedics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Merck

Johnson & Johnson

BioLineRx Ltd

Pfizer Inc

Innovate Biopharmaceuticals

ImmusanT

Novartis

Bristol–Myers Squibb

Immunomedics

List of Tables

Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Distension

Table 3. Key Players of Diarrhea

Table 4. Key Players of Anorexia

Table 5. Key Players of Others

Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Celiac Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Celiac Disease Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Celiac Disease Market Share by Region (2020-2025)

Table 10. Global Celiac Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Celiac Disease Market Share by Region (2026-2031)

Table 12. Celiac Disease Market Trends

Table 13. Celiac Disease Market Drivers

Table 14. Celiac Disease Market Challenges

Table 15. Celiac Disease Market Restraints

Table 16. Global Celiac Disease Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Celiac Disease Market Share by Players (2020-2025)

Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2024)

Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Celiac Disease, Headquarters and Area Served

Table 22. Global Key Players of Celiac Disease, Product and Application

Table 23. Global Key Players of Celiac Disease, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Celiac Disease Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Celiac Disease Revenue Market Share by Type (2020-2025)

Table 27. Global Celiac Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Celiac Disease Revenue Market Share by Type (2026-2031)

Table 29. Global Celiac Disease Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Celiac Disease Revenue Market Share by Application (2020-2025)

Table 31. Global Celiac Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Celiac Disease Revenue Market Share by Application (2026-2031)

Table 33. North America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Celiac Disease Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Celiac Disease Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Celiac Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Celiac Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Celiac Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Celiac Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Celiac Disease Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Celiac Disease Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Celiac Disease Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Celiac Disease Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Celiac Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Celiac Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Celiac Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Celiac Disease Product

Table 51. Roche Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Merck Company Details

Table 54. Merck Business Overview

Table 55. Merck Celiac Disease Product

Table 56. Merck Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 57. Merck Recent Development

Table 58. Johnson & Johnson Company Details

Table 59. Johnson & Johnson Business Overview

Table 60. Johnson & Johnson Celiac Disease Product

Table 61. Johnson & Johnson Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 62. Johnson & Johnson Recent Development

Table 63. BiolineRx Company Details

Table 64. BiolineRx Business Overview

Table 65. BiolineRx Celiac Disease Product

Table 66. BiolineRx Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 67. BiolineRx Recent Development

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer Celiac Disease Product

Table 71. Pfizer Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 72. Pfizer Recent Development

Table 73. Innovate Biopharmaceuticals Company Details

Table 74. Innovate Biopharmaceuticals Business Overview

Table 75. Innovate Biopharmaceuticals Celiac Disease Product

Table 76. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 77. Innovate Biopharmaceuticals Recent Development

Table 78. ImmusanT Company Details

Table 79. ImmusanT Business Overview

Table 80. ImmusanT Celiac Disease Product

Table 81. ImmusanT Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 82. ImmusanT Recent Development

Table 83. Novartis Company Details

Table 84. Novartis Business Overview

Table 85. Novartis Celiac Disease Product

Table 86. Novartis Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 87. Novartis Recent Development

Table 88. Bristol-Myers Squibb Company Details

Table 89. Bristol-Myers Squibb Business Overview

Table 90. Bristol-Myers Squibb Celiac Disease Product

Table 91. Bristol-Myers Squibb Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 92. Bristol-Myers Squibb Recent Development

Table 93. Immunomedics Company Details

Table 94. Immunomedics Business Overview

Table 95. Immunomedics Celiac Disease Product

Table 96. Immunomedics Revenue in Celiac Disease Business (2020-2025) & (US$ Million)

Table 97. Immunomedics Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Celiac Disease Picture

Figure 2. Global Celiac Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Celiac Disease Market Share by Type: 2024 VS 2031

Figure 4. Distension Features

Figure 5. Diarrhea Features

Figure 6. Anorexia Features

Figure 7. Others Features

Figure 8. Global Celiac Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Celiac Disease Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Celiac Disease Report Years Considered

Figure 13. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Celiac Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Celiac Disease Market Share by Region: 2024 VS 2031

Figure 16. Global Celiac Disease Market Share by Players in 2024

Figure 17. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2024

Figure 19. North America Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Celiac Disease Market Share by Country (2020-2031)

Figure 21. United States Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Celiac Disease Market Share by Country (2020-2031)

Figure 25. Germany Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Celiac Disease Market Share by Region (2020-2031)

Figure 33. China Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Celiac Disease Market Share by Country (2020-2031)

Figure 41. Mexico Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Celiac Disease Market Share by Country (2020-2031)

Figure 45. Turkey Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Celiac Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 51. BiolineRx Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 53. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 54. ImmusanT Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 57. Immunomedics Revenue Growth Rate in Celiac Disease Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions